Dr A P Moore


Dr A P Moore




General neurology and movement disorders, including Parkinson’s disease, dystonia, spasticity, and treatment with botulinum toxins.


Consultant Neurologist at The Walton Centre NHS Foundation Trust,
Honorary Senior Lecturer in Neurology at Liverpool University.




Fellow of Royal College Physicians,
Association of British Neurologists,
Movement Disorders Society,
Cochrane Collaboration,
North East England Neurological Association,
DeNDRoN & its Parkinson’s disease research group,
UK Botulinum Toxin Injector’s Group,
Fellow of Higher Education Academy.

Professional Profile

I run two or three general neurology outpatient clinics each week at The Walton Centre and Aintree University Hospital. I see ward referrals at Aintree University Hospital twice a week. I look after inpatients at The Walton Centre and share the on-call rota there with the other neurologists. I run five subspecialty clinics each month for movement disorders, with a special interest in botulinum toxin treatment of dystonia, spasticity and other problems. I regularly teach medical, paramedical and postgraduate students, and run training for botulinum toxin treatment, locally and internationally. For the Movement Disorder Society I currently run training in botulinum toxin treatment at its major meetings, and in stand-alone meetings. I have recently served on its Worldwide Education Committee. I am co-author of ‘Handbook of botulinum toxin treatment’, and produced the Movement Disorders Society CD ‘Guide to botulinum toxin injections’ in 2004.

Research Interests

I have run or participated in many clinical trials in Parkinson’s disease, dystonia and spasticity and remain active in these fields, especially the uses of botulinum toxin. As a member of DeNDRoN I help coordinate and direct Parkinson’s disease research in the UK. As a founding committee member and editor for the Movement Disorders Group of the Cochrane Collaboration I facilitate production of its systematic reviews. I write reviews on my own research interests as above. I have co-authored guidelines on treatment of Parkinson’s disease and the use of botulinum toxins.